(ADA:German Stock Exchange)
Michael D. Kishbauch
Director and Chairman of Strategy & Corporate Development Committee,Achillion Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 41 board members in 3 different organizations across 6 different industries.|
See Board Relationships
Mr. Michael D. Kishbauch, also known as Mike, served as the Chief Executive Officer and President of Achillion Pharmaceuticals, Inc. from July 2004 to May 2013. Mr. Kishbauch founded of OraPharma, Inc., and served as its President and Chief Executive Officer since September 1996 and again from September 2000 to July 2004. He joined J&J and served as its President of the OraPharma division. He served as President and Chief Operating Officer at two business units at Nelson ...
300 George StreetPhone: 203-624-7000
New Haven, Connecticut 06511
Board Members Memberships*
Director and Chairman of Strategy & Corporate Development Committee
Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
University of Pennsylvania - The Wharton School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|M. Michelle Berrey M.D., MPH.||Chief Executive Officer, President, Chief Medical Officer and Director|
|John M. Gill CPA||Chief Executive Officer, President and Director|
|Paul Chaplin MSc, Ph.D.||Chief Executive Officer and President|
Bavarian Nordic A/S
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|